Novo Nordisk A/S
DUS:NOV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Novo Nordisk A/S
DUS:NOV
|
DK |
|
D
|
DaVita Inc
XMUN:TRL
|
US |
|
T
|
TeamLease Services Ltd
BSE:539658
|
IN |
|
T
|
Takashimaya Co Ltd
DUS:TKM
|
JP |
|
B
|
Bridgestone Corp
DUS:BGT
|
JP |
|
Ferrovial SA
BMV:FERN
|
ES |
|
Bridgestone Corp
F:BGT
|
JP |
|
Noble Corporation PLC
F:85V1
|
US |
Wall St Price Targets
NOV Price Targets Summary
Novo Nordisk A/S
According to Wall Street analysts, the average 1-year price target for NOV is 43 EUR with a low forecast of 26.5 EUR and a high forecast of 62.54 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NOV's stock price target?
Price Target
43
EUR
According to Wall Street analysts, the average 1-year price target for NOV is 43 EUR with a low forecast of 26.5 EUR and a high forecast of 62.54 EUR.
What is the Revenue forecast for Novo Nordisk A/S?
Projected CAGR
1%
Over the last 14 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 1%.
What is the Gross Profit forecast for Novo Nordisk A/S?
Projected CAGR
2%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 3 years is 2%.
What is the Operating Income forecast for Novo Nordisk A/S?
Projected CAGR
2%
Over the last 14 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 2%.
What is the Pre-Tax Income forecast for Novo Nordisk A/S?
Projected CAGR
0%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 14%. The projected CAGR for the next 3 years is 0%.
What is the Net Income forecast for Novo Nordisk A/S?
Projected CAGR
-1%
Over the last 14 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 3 years is -1%.
